SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
XBI Analysis & Videos »
XBI: Bull or Bear?
The best ETFs for betting on biotech
XBI
-4.45%
in
117 days
Filed under: Newsletters, Stocks to Buy "I'm always looking for market leadership; right now, biotechnology stocks are moving up faster than most anything else," says Ron Rowland. In Money & Markets, he eyes biotech ETFs. "Biotechnology is a fascinating sector, one that's made (and lost) a lot of money for millions of investors in recent decades. That's why, in my opinion, you should become familiar with this industry. "Broadly speaking, it's the application of technology to biological materials - plants, animals and people. <>"Nowadays a lot of biotechnology involves manipulating genetic materia...
|
Biotech ETFs: Best bets on health care reform
XBI
+13.04%
in
32 days
(closed on 08/11/09)
Filed under: Newsletters, ETF Investing, Stocks to Buy, Obama Picks  "Health care reform could mean opportunities for astute investors," says Brandon Clay in his Invest With an Edge.
Here, eyes two biotech ETFs that "should be on everyone's watch list." The advisor notes, "With health care on the front burner in Washington, these biotechnology ETFs may finally be ready to pop." "Investors in health care should think outside the realm of traditional pharmaceutical companies and health insurers. Those sectors are each facing headwinds that make stock picking difficult. <>"In addition, several big ph...
|
Bullish on XBI ...
XBI
|
|
|
+5.48%
in
257 days
SPDR S&P Biotech (XBI) The goal of this exchange traded fund is to replicate the performance of the S&P Biotechnology Select Industry Index. It is passively managed, in that there is no trading in the fund unless there is a change to the underlying index. With close to $500 million in assets, the XBI has an average daily trading volume of nearly 260,000 shares. As for the underlying index, biotechnology is one of the few things working in this horrible economic environment. The drama being played out by Roche and Genentech (DNA) evidences the interest in this all important sector. Fro...
|
New Website for Healthcare Investors and Traders
XBI
|
|
|
-6.68%
in
136 days
(closed on 06/26/09)
<> A new website for healthcare investors and traders should be ready to launch by the end of February, which is designed to provide users with more features beyond my current blog format.
The site will feature its own blog, discussion forum, news feeds, videos, stock commentaries (including multiple contributors), and other unique content – including my FDA and Clinical Trial Calendars plus a database that includes hundreds of foreign and U.S.-listed stocks in the healthcare sector which are organized into unique indexes, including:
1....
|
One Year Analysis of Healthcare ETFs
XBI
|
|
|
+6.24%
in
19 days
(closed on 02/10/09)
<> The table at my website link below includes a summary and statistics for the 25 healthcare exchange-traded funds (ETFs) which are currently on the market. The group posted a 23.5% loss over the past year on an equal-weight basis with an average of about $400M in net assets. However, the top eight ETFs by net assets account for 88.5% of all net assets for the entire group of 25, including Healthcare Sector SPDR (XLV), Pharma HOLDRs (PPH), iShares Nasdaq Biotech (IBB), Biotech HOLDRs (BBH), iShares Dow Jones U.S. Healthcare (IYH), iShares S&P Global Healthcare (IXJ), Vanguard Healthcare (VHT...
|
Obama Picks: Fund expert's top ETFs
XBI
-13.47%
in
246 days
(closed on 07/10/09)
Filed under: Newsletters, Mutual funds, Presidential elections, Commodities, Oil, Agriculture, Stocks to Buy, Green Stocks, Obama Picks What sectors are poised to outperform as a result of a Barack Obama presidency? To find out, we turn to fund expert Jim Lowell who recent prepared a report highlighting the top ETFs based on each candidate. In The Forbes ETF Trader, he offers several top picks including ETFs that are focused on biotechnology and medical research, industrials, clean environment and clean energy technologies. <>"SPDR Biotech (ASE: XBI) seeks investment results that correspond to...
|
Healthcare ETFs Outpace the Market
XBI
|
|
|
-4.80%
in
81 days
(closed on 01/22/09)
<> 
The accompanying table presents an analysis and statistics for the 28 healthcare ETFs listed at the Yahoo! Finance ETF Center. As a group, the healthcare ETFs outpaced the overall market in the past year by more than 10%, posting an average loss of 26.5% compared to a loss of 37.4% for the S&P 500 SPDR ETF (SPY). The best performing healthcare ETF was the Biotech HOLDRs (BBH), thanks to a buyout bid for top holding Genetech (DNA) and solid earnings results this year for the number two position, Amgen (AMGN).
The top three...
|
Bet on a biotech bull
XBI
+4.75%
in
19 days
(closed on 11/05/08)
Filed under: Newsletters, Mutual funds, Stocks to Buy "Bull markets have been few and far between this summer; one of the few sectors that looks to have re-entered a bull trend is biotechnology," says international investing expert Nick Vardy. In his Global Bull Market Alert, he explains, "The S&P Biotech ETF (ASE: XBI) looks to capitalize on this traditionally highly volatile and boom bust burdened sector." Here's his bullish assessment. <>"Why the sudden merger and acquisitions frenzy in biotech? Put simply, 'Big Pharma' is cash-rich but innovation-poor. As patents expire, the traditional phar...
|
New biotech bull? Bet on S&P Biotech ETF (XBI)
XBI
-15.84%
in
21 days
(closed on 10/17/08)
Filed under: Newsletters, Stocks to Buy "Bull markets have been few and far between this summer; one of the few sectors that looks to have re-entered a bull trend is biotechnology," says international investing expert Nick Vardy. In his Global Bull Market Alert, he explains, "The S&P Biotech ETF (ASE: XBI) looks to capitalize on this traditionally highly volatile and boom bust burdened sector." Here's his bullish assessment. "Why the sudden merger and acquisitions frenzy in biotech? Put simply, 'Big Pharma' is cash-rich but innovation-poor. <>"As patents on huge profit generators such as Pfizer's...
|
A Biotech Bloom in July
XBI
-21.68%
in
495 days
The best performing sector in the past month has been biotech. With investors flocking to safety due to recent financial turmoil and the sharp correction in energy, funds and investors have been warming up to biotech. <>The biotech sector is not without its large risks though and investing here requires more homework and experience than most sectors. The biotech landscape is full of landmines especially with unproven companies with their yet to be proven drugs. The recent backlash the FDA has received due to major flaws in its Vioxx approval and other well publicized failed post approval drugs...
|
People Bullish on XBI
People Bearish on XBI
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Be the first to start a discussion and earn 2 points.
More Resources
|
About SPDR S&P Biotech ETF
- Answers.com
